Forum: Clinical Trials
06-17-2007, 04:37 AM
|
Replies: 0
Views: 2,357
Phase I Trial Of VB6-845 Anti-Cancer Antibody
http://www.emaxhealth.com/51/12884.html
Viventia Biotech Initiates Patient Treatment For Phase I Trial Of VB6-845 Anti-Cancer Antibody
Viventia Biotech has initiated patient dosing for its...
|